Discovery of Spirofused Piperazine and Diazepane Amides as Selective Histamine-3 Antagonists with in Vivo Efficacy in a Mouse Model of Cognition

Citations Over TimeTop 22% of 2014 papers

Abstract

A new series of potent and selective histamine-3 receptor (H3R) antagonists was identified on the basis of an azaspiro[2.5]octane carboxamide scaffold. Many scaffold modifications were largely tolerated, resulting in nanomolar-potent compounds in the H3R functional assay. Exemplar compound 6s demonstrated a selective profile against a panel of 144 secondary pharmacological receptors, with activity at only σ2 (62% at 10 μM). Compound 6s demonstrated free-plasma exposures above the IC50 (∼50×) with a brain-to-plasma ratio of ∼3 following intravenous dosing in mice. At three doses tested in the mouse novel object recognition model (1, 3, and 10 mg/kg s.c.), 6s demonstrated a statistically significant response compared with the control group. This series represents a new scaffold of H3 receptor antagonists that demonstrates in vivo exposure and efficacy in an animal model of cognition.

Related Papers

• → Density and Viscosity of Aqueous Solutions of Piperazine and (2-Amino-2-methyl-1-propanol + Piperazine) from 298 to 333 K(2006)91 cited
• → Synthesis and characterization of a series of phenyl piperazine based ligands(2020)9 cited
• → Sequential mono-N-arylation of piperazine nitrogens. Part 1: A simplified method and its application to the preparation of a key N,N′-biaryl piperazine antifungal intermediate(1999)27 cited
• → Spectrophotometric Determination of Piperazine in Pharmaceutical Preparations(1974)2 cited
• SYNTHESIS, CHARACTERISATION AND ANTIBACTERIAL ACTIVITY OF FLUORINE-CONTAINING DERIVATIVES OF PIPERAZINE AND MORPHOLINE(2014)